section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

When used in combination with other antiretrovirals

CV: PR interval prolongation, heart block

Derm: DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS), ERYTHEMA MULTIFORME, rash, STEVENS-JOHNSON SYNDROME

Endo: Graves' disease, hyperglycemia

GI: nausea, liver enzymes, abdominal pain, autoimmune hepatitis, cholelithiasis, diarrhea, HEPATOTOXICITY, hyperbilirubinemia, jaundice, vomiting

GU: interstitial nephritis, nephrolithiasis

Metab: fat redistribution

MS: myalgia, polymyositis

Neuro: depression, dizziness, Guillain-Barré syndrome, headache, insomnia

Misc: ANGIOEDEMA, fever, immune reconstitution syndrome

Interactions

Drug-drug:

Drug-Natural Products:

Availability

(Generic available)

Route/Dosage

Renal Impairment

Hepatic Impairment

US Brand Names

Reyataz

Action

  • Inhibits the action of HIV protease, preventing maturation of virions.
Therapeutic effects:
  • CD4 cell counts and viral load with subsequent slowed progression of HIV and its sequelae.

Classifications

Therapeutic Classification: antiretrovirals

Pharmacologic Classification: protease inhibitors

Pharmacokinetics

Absorption: Rapidly absorbed ( by food).

Distribution: Enters CSF and semen.

Metabolism/Excretion: Primarily metabolized by the liver via the CYP3A isoenzyme; 13% excreted unchanged in urine.

Half-Life: 7 hr.

Time/Action Profile

(plasma concentrations)

ROUTEONSETPEAKDURATION
POrapid2.5 hr24 hr



Patient/Family Teaching

Pronunciation

a-ta-ZAN-a-veer